Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOPE: Saline washouts versus standard treatment in complicated parapneumonic pleural effusion or empyema
2019-003542-32Phase 4Active
- Sponsor
- Dr. José Manuel Porcel Pérez
- Start
- Feb 2020
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of dornase alfa, urokinase and sodium chloride in parapneumonic effusion and Empyema Thoracis (3 arms), sponsored by Dr. José Manuel Porcel Pérez. Primary endpoint: Duration of pleural drainage. Started Feb 2020; status: active.
02
Drugs
dornase alfaurokinasesodium chloride
03
Conditions
parapneumonic effusionEmpyema Thoracis
Beyond the preview
Go deeper on 2019-003542-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003542-32.